K Number
K092482
Device Name
TISSU TRANS FILTRON, MODELS 3-TT-FILTRON 2000-500
Date Cleared
2009-12-04

(113 days)

Product Code
Regulation Number
878.5040
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Tissu Trans Filtron is intended to be used with house vacuum and/or cleared pumps, tubing and cannulas, for the collection of aspirated fat, for aesthetic body contouring. If the fat is untreated, it may be reinjected via a cleared injection apparatus. Tissu Trans Filtron is used in the aspiration, harvesting, filtering and transferring of autologous tissue, Tissu Trans Filtron is intended for use in the following surgical specialties when the aspiration of soft tissue is desired: - Plastic and Reconstructive Surgery - Neurosurgery - Gastrointestinal and Affiliated Organ surgery - Urological Surgery - Orthopedic surgery - Gynecological Surgery - Thoracic surgery - Laparoscopic Surgery
Device Description
The Tissu Trans Filtron is provided in a sterile, two piece packaged assembly: The Tissu Trans Filtron. The Tissu Trans Filtron is a single-use, sterile, disposable device designed to utilize an FDA, cleared house vacuum to create suction within the physician supplied hollow liposuction cannula and remove subcutaneous fatty tissue from the patient and transport the autologous tissue into the collection canister. The Tissu Trans Filtron is a sterile, single-use, manual device consisting of a medical grade polycarbonate canister, a medical grade polypropylene lid with various ports, medical grade silicone connection tubings for aspiration of waste, harvesting of tissue and transferring of filtered autologous tissue. A polypropylene clamp is included for clamping off the tubing as needed. A medical grade polyester mesh filter lining is contained within the canister.
More Information

k 072587, K050797

Not Found

No
The device description and intended use focus on a manual, single-use device for fat aspiration and filtration. There is no mention of AI, ML, image processing, or any computational analysis of data. The performance studies are mechanical and clinical, not related to algorithmic performance.

No.
The Tissu Trans Filtron is intended for the collection, aspiration, harvesting, filtering, and transferring of autologous tissue, specifically fat for aesthetic body contouring and soft tissue in various surgical specialties. While it is used in a medical context, its primary function is collection and preparation of tissue, not directly providing therapy or treatment of a disease or condition. The reinjection of the fat (if untreated) is then done via a separate cleared injection apparatus, making the Trans Filtron a preparation device rather than a therapeutic device in itself.

No

The device description and intended use clearly state that the Tissu Trans Filtron is for the collection, aspiration, harvesting, filtering, and transferring of fat/tissue for body contouring and other surgical specialties. There is no mention of diagnostic functions or capabilities.

No

The device description clearly outlines physical components such as a canister, lid, ports, tubing, clamp, and filter, indicating it is a hardware device, not software-only.

Based on the provided information, the Tissu Trans Filtron is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states the device is for the collection, filtering, and transfer of aspirated fat for aesthetic body contouring and potential reinjection. This is a surgical procedure involving the patient's body directly, not a test performed on a sample outside the body to diagnose a condition.
  • Device Description: The description details a device for aspirating and filtering tissue from the patient. It's a tool used during a surgical procedure.
  • Lack of IVD Characteristics: There is no mention of the device being used to analyze a sample for diagnostic purposes, detect specific substances, or provide information about a patient's health status based on a biological sample.

IVD devices are typically used to examine samples like blood, urine, tissue biopsies, etc., in vitro (outside the body) to provide diagnostic information. The Tissu Trans Filtron is a surgical tool used in vivo (within the body) for tissue manipulation.

N/A

Intended Use / Indications for Use

The Tissu Trans Filtron is intended to be used with house vacuum and/or cleared pumps, tubing and cannulas, for the collection of aspirated fat, for aesthetic body contouring. If the fat is untreated, it may be reinjected via a cleared injection apparatus.

Tissu Trans Filtron is used in the aspiration, harvesting, filtering and transferring of autologous tissue,

Tissu Trans Filtron is intended for use in the following surgical specialties when the aspiration of soft tissue is desired:

  • Plastic and Reconstructive Surgery
  • Neurosurgery
  • Gastrointestinal and Affiliated Organ surgery
  • Urological Surgery
  • Orthopedic surgery
  • Gynecological Surgery
  • Thoracic surgery
  • Laparoscopic Surgery

Product codes (comma separated list FDA assigned to the subject device)

MUU

Device Description

The Tissu Trans Filtron is provided in a sterile, two piece packaged assembly: The Tissu Trans Filtron. The Tissu Trans Filtron is a single-use, sterile, disposable device designed to utilize an FDA, cleared house vacuum to create suction within the physician supplied hollow liposuction cannula and remove subcutaneous fatty tissue from the patient and transport the autologous tissue into the collection canister.

DEVICE COMPONENTS:
The Tissu Trans Filtron is a sterile, single-use, manual device consisting of a medical grade polycarbonate canister, a medical grade polypropylene lid with various ports, medical grade silicone connection tubings for aspiration of waste, harvesting of tissue and transferring of filtered autologous tissue. A polypropylene clamp is included for clamping off the tubing as needed. A medical grade polyester mesh filter lining is contained within the canister.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

IN VITRO TESTING:
Mechanical testing of the Tissu Trans Filtron demonstrates that the device is substantially equivalent to the predicate device. Device Performance was satisfied by clinical testing performed by Ronald Shippert, M.D. All testing proved to be safe and effective. The device performed as desired and was as safe and as effective as the predicate devices.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

Cytori AFT System, k 072587, Shippert Medical's " Tissu Trans", K050797, Genesis Biosystems Lipivage k# unknown

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 878.5040 Suction lipoplasty system.

(a)
Identification. A suction lipoplasty system is a device intended for aesthetic body contouring. The device consists of a powered suction pump (containing a microbial filter on the exhaust and a microbial in-line filter in the connecting tubing between the collection bottle and the safety trap), collection bottle, cannula, and connecting tube. The microbial filters, tubing, collection bottle, and cannula must be capable of being changed between patients. The powered suction pump has a motor with a minimum of1/3 horsepower, a variable vacuum range from 0 to 29.9 inches of mercury, vacuum control valves to regulate the vacuum with accompanying vacuum gauges, a single or double rotary vane (with or without oil), a single or double diaphragm, a single or double piston, and a safety trap.(b)
Classification. Class II (special controls). Consensus standards and labeling restrictions.

0

Shippert Medical Technologies

The Denver Splint Company

6248 S. Troy Circle, Unit A Centennial, CO 80111 Telephone 1-800-888-8663 (303) 754-0044 Facsimile 1-800-284-0864 (303) 754-0318 Website www.shippertmedical.com

DEC - 4 2009

510(k) SUMMARY Section 5:

K 092482510(k) SummaryTissu Trans FiltronPage 1 of 5
------------------------------------------------------------

| Name: | Shippert Medical Technologies
6248 South Troy Circle, Unit A
Centennial, Colorado 80111 |
|-------|-----------------------------------------------------------------------------------------------|
| Tele: | 303.754.0044 |
| Fax: | 303.754.0318 |

Date:December 4, 2009
-------------------------
Official Contact:Sarah Lake Shippert
email: sarah@shippertmedical.com
Telephone (303) 888.4965
Submitted by:Sarah Lake Shippert
------------------------------------

FDA ESTABLISHMENT REGISTRATION NUMBER: 1718903

DEVICE NAME: Tissu Trans Filtron

Tradename:Tissu Trans Filtron
Common Name:Suction Lipoplasty System
Classification name:Suction Lipoplasty System
Tradename:Tissu Trans Filtron
Common Name:Suction Lipoplasty System
Classification name:Suction Lipoplasty System
Product Code:MUU
Regulation Number:21 CFR 878.5040
Class IISterile

DEVICE CLASSIFICATION AND PRODUCT CODE:

As shown in 21 CFR 878.5040 Suction Lipoplasty Systems are defined as devices consisting of collection bottles, cannulas, and connecting tubing for use in aesthetic body contouring procedures. Suction Lipoplasty Systems are classified as Class II. They have been assigned Product Code MUL.

20 191841836.

1

092482 4/5

K 092482

-10(k) Summary

510(k) Summary

INDICATIONS FOR USE:

The Tissu Trans Filtron is intended to be used with house vacuum and/or cleared pumps, tubing and cannulas, for the collection of aspirated fat, for aesthetic body contouring. If the fat is untreated, it may be reinject rid, it a cleared injection apparatus.

INTENDED USE:

The Tissu Trans Filtron is intended to be used with house vacuum and/or cleared pumps, tubing and cannulas, for the collection of aspirated fat, for aesthetic boody contouring. If the fat is untreated, it may be reinjected via a cleared injection apparatus.

Tissu Trans Filtron is used in the aspiration, harvesting, filtering and transferring of autologous tissue,

Tissu Trans Filtron is intended for use in the following surgical specialties when the aspiration of soft tissue is desired:

  • Plastic and Reconstructive Surgery

  • Plastic and Reconstructive Surgery
    Neurosurgery
    Gastrointestinal and Affiliated Organ surgery With I . Suspins
    Gastrointestinal and Affiliated Organ surgery Housery Housery

  • Urological Surgery

  • Orthopedic surgery .

  • Gynecological Surgery

  • Thoracic surgery

  • Laparoscopic Surgery

DESIGN CHARACTERISTICS: 2 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 The Tissu Trans Filtron is provided in a sterile, two piece packaged assembly: The Tissu Trans Filtron. The Tissu Trans Filtron is a single-use, sterile, disposable device designed to utilize an FDA, cleared house vacuum to create suction within the physician supplied hollow liposuction cannula and remove subcutaneous fatty tissue from the patient and transport the autologous tissue into the collection canister. The patient and transport the adiologics than

2

c092482315

K 092482 510(k) Summary

Tissu Trans Filtron

Page 3 of 5

12 at 19

DEVICE COMPONENTS:

The Tissu Trans Filtron is a sterile, single-use, manual device consisting of a medical grade polycarbonate canister, a medical grade polypropylene lid with various ports, medical grade silicone connection tubings for aspiration of waste, harvesting of tissue and transferring of filtered autologous tissue. A polypropylene clamp is included for clamping off the tubing as needed. A medical grade polyester mesh filter lining is contained within the canister.

Material Composition:

The components of the Tissu Trans Filtron do not have direct patient contact. The necessary FDA cleared liposuction cannula (direct patient contact) is supplied by the physican.

All components of the Tissu Trans Filtron have been tested and have passed the ISO 10993 testing regimen for External Communication Devices, Tissue contact, of less than 24 hours. All necessary biocompatibility testing was performed on the sterile, finished device.

STERILITY:

The Tissu Trans Filtron is sterilized by Gamma Radiation.

IN VITRO TESTING:

Mechanical testing of the Tissu Trans Filtron demonstrates that the device is substantially equivalent to the predicate device. Device Performance was satisfied by clinical testing performed by Ronald Shippert, M.D. All testing proved to be safe and effective. The device performed as desired and was as safe and as effective as the predicate devices.

EQUIVALENCE TO MARKETED DEVICES:

The Tissu Trans Filtron share indications and design principles with the following predicate devices which have been determined by FDA to be substantially equivalent to premarket devices: Cytori AFT System K072587 Tissu Trans K050797, and Genesis Biosystems Lipivage (510(k) number unknown); Class I and Class II medical devices that were cleared for marketing in the United States.

Design and Materials:

The design and materials of the Tissu. Trans Filtron and the predicate devices, (Cytori AFT System 072587, Shippert Medical Tissu Trans k 050797, Genesis Biosystems Lipivage id unknown, are substantially equivalent, as they are all single-use, polymer constructed, manually operated systems that utilize manual.

1 per 1991 1 1991 11 11:11 11 11:11 11.

ar son the call home . and ... .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3

c0474824/5

K 092482 510(k) Summary

Tissu Trans Filtron

Page 4 of 5

or external sources of vacuum to withdraw, hold, and/or inject fluids/tissues into the body. The Tissu Trans Filtron is substantially equivalent to the Cytor AFT System K072587, The Shippert Medical Tissu Trans K050797 and the Lipivage k# unknown, predicate devices as they all consist of a polycarbonate tissue collection canister and they share design principles of utilizing an FDA cleared house-vacuum to aspirate adipose tissue from the patient and subsequently transport the adipose tissue through a tube into a cylindrical collection chary that contains a filtering mechanism of pores to allow fluids to pass, but retains the adipose tissue within the filter chamber. The Tissu Trans Filtron is substantially equivalent to the Cytori AFT System K072587, Shippert Medical's Tissu Trans 050797 and Genesis Biosystems Lipivage k# unknown, as they all have connection ports on the superior ends of the housing chamber for the attachment of suction tubing/stainless steel cannulas that contact the patient and connection ports on the inferior end of the housing chamber to connect to vacuum tubing that draws house vacuum and carries waste to the waste trap.

Substantial Equivalence: _Shippert Medical Technologies claim substantial equivalence to the predicate devices. Predicate Device # 1: Cytori AFT System , k 072587 Classification Name: Suction Lipoplasty System

Class 2 Device, Product Code MUU 、 Concrol Hoopital Olamber 878.5040 at at a polycharners 31 2 11-2 General Hospital Classification Advisory Committee [-General & Plastic Surgery Review Advisory Committee ചിത്രീരത്തിനു

and

Predicate Device # 2: Shippert Medical's " Tissu Trans", K050797

Classification name: Syringe, Irrigating ( Non Dental) Class 1 Device, Sterile 11 - 11 ្រ : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :

Product Code: KYZ Regulation #: 880.6960.net=" +t-chaitact the pating(the should and conner General Hospital Classification Advisory Committee General & Plastic Surgery Review Advisory Committee

and

Predicate Device # 3

Genesis Biosystems Lipivage k# unknown

Classification name:

Class 2 Device, Sterile

Product Code: MUU Stiction | proplesty System

Regulation #: 878.5040

General Hospital Classification Advisory Committee General & Plastic Surgery Review Advisory Committee

4

1-092482 5/5

K 092482

O(k) Summary:

510(k) Summary

    • Page 5 of 5

Summary: The Shippert Medical Tissu Trans Filtron device described in this submission is substantially equivalent to the predicate devices and is safe and effective. The proposed device and predicate devices have identical "Internded Use" and similar Indications For Use" and also share similar design and technological principles. The device design and materials used are similar to those of the Predicate Devices, Cytori AFT System k 072587, Shippert Medical Tissu Trans, K05079 and Genesis Biosystems Lipivage k# unknown,

As stated in CFR 878.5040, (product code MUU),

a., "Identification. A suction lipoplasty system is a device intended for aesthetic body contouring. The device consists of a powered suction pump (containing a microbial filter on the exhaust and a microbial in-line filter in the connection tubing between the collection bottle and the safety trap), collection bottle, cannula, and connecting tube. The microbial filters, tubing, collection bottle, and cannula must be capable of being changed between patients. The powered suction pump has a motor with a minimum of 1/3 horsepower, a variable vacuum range from 0 - 29.9 inches of mercury, vacuum control valves to regulate the vacuum with accompanying vacuum gauges, a single or double rotary vane ( with or without oil), a single or double diaphragm, a single or double piston, and a safety trap.

Given the "Intended Use", "Indications For Use", device technology, materials and basic design structure of Product Code MUU, & KYZ, Shippert,Medical Technologies claim Substantial Equivalence to the above listed devices.

Bred Callen plant (CC . 1 ago to ways a more al instine niters in the bonnection But safety trap), collection bo tually : collegeli

ICL

5

Tissu Trans Filtron™ Indications For Use; The Tissu Trans Filtron Is intended to be used with house vacuum and/or cleared The Tissu Trans Filtron is intenced to be used into notated for aesthetic body

pumps, tubing and cannot to the collection, of aspirated for a segment of the color appar pumps, tubing and cannulas, for the collections. It is a cleared injection apparatur Tissu Trans Filtron is used in the aspiration in and transfering of anyalting of a viralize of Soft tissue is Tissu Trans Filtron is used in the following surgical specialites when the aspection of soft tissue is
Trans Filtron is intended for use in the following surgical and Afrikan Trans Filtron's intended for use in the rolowing sorginal and Afiliated Organ Surgery.
desired: Plastic and Reconstructive Surgery, NEIrosellent Laborosophy, Surgey. desired: Plastic and Reconstructive Surgery, Neurosal Surgery, Thoracic Surgery, Labaroscopic Surgery, Labaroscopic Surgery, Product Code: 3-TT-Filtron 2000-500 Contents: 1 Tissu Trans Filtron Unit with 6" Harvest Tubling Revised Indications For Use Revised Summary.

Hard copies will follow by mail along with revised labeling.

Thank you,

Yarich Shippert

Sarah Lake Shippert

7

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/7/Picture/1 description: The image shows the seal for the Department of Health & Human Services (HHS). The seal is composed of two main elements: a circular text border and a central emblem. The text border reads "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" in a circular arrangement. The emblem features a stylized depiction of an eagle with outstretched wings, symbolizing the department's mission to protect and promote the health and well-being of the nation.

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room W-O66-0609 Silver Spring, MD 20993-0002

Shippert Medical Technologies Corp. % Ms. Sarah Shippert Head, Regulatory Affairs 6428 South Troy Circle, Unit A Centennial, Colorado 80111

Re: K092482

Trade/Device Name: Tissu Trans Filtron Regulation Number: 21 CFR 878.5040 Regulation Name: Suction lipoplasty system Regulatory Class: II Product Code: MUU Dated: November 17, 2009 Received: November 27, 2009

DEC - 4 2009

Dear Ms. Shippert:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

8

Page 2 - Ms. Sarah Shippert

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Joxutti

Mark N. Melkerson Director Division of Surgical, Orthopedic, and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

9

Indications For Us

510k Number if known: K092482

Device Name: Tissu Trans Filtron

Indications for Use:

The Tlssu Trans Filtron is intended to be used with house vacuum and/or cleared pumps, tubing and cannulas, for the collection of aspirated fat, for aesthetic body contouring. If the fat is untreated, it may be reinjected via a cleared injection apparatus.

Prescription Use Over-The

11 15 - - 45

(Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED

----------1 Par ... 12 . 3 . 2 . 2 . 000000000000000000000000000 car a smalle coay-contauring fir the fat'is untrautod, it Concurrence of CDRH Office of Device Evaluation (O)

David Kramer
(Division-Sign-Off)

1 - 124

. The The First of the state of the state of the state of the state of the state of the state of the state of the state of the state of the state of the state of the state of Division of Surgical, Orthopedic, and Restorative Devices

510(k) Number K092462